Emergent BioSolutions(EBS) - 2025 Q1 - Quarterly Results
Emergent BioSolutions(US:EBS)2025-05-07 20:08| ($ in millions, except per share amounts) | | Q1 2025 | | Q1 2024 | % Change | | --- | --- | --- | --- | --- | --- | | Total Revenues | $ | 222.2 | $ | 300.4 | (26)% | | Net Income | $ | 68.0 | $ | 9.0 | 656 % | | Net Income per Diluted Share | $ | 1.19 | $ | 0.17 | 600 % | | (2) Adjusted Net Income | $ | 40.7 | $ | 31.1 | 31 % | | (2) Adjusted Net Income per Diluted Share | $ | 0.71 | $ | 0.59 | 20 % | | (2) Adjusted EBITDA | $ | 77.6 | $ | 66.9 | 16 % | | (2) Adjusted EBITDA Margin | | 35 % | | 22 % | | ...